Further evidence for the association of MMP9 with nephropathy in type 2 diabetes and application of DNA pooling technology to candidate gene screening

Journal of Nephrology

Volumn 21, Issue 3, 2008, Pages 400-405

  Nair, Sunita ^a   Phillips, Aled O ^a   Norton, Nadine ^a   Spurlock, Gillian ^a   Williams, Hywel J ^a   Craig, Kathrine J ^b   Williams, John D ^a   Williams, Nigel M ^a   Bowen, Timothy ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Diabetic nephropathy; Hyaluronan synthase genes; MMP9; SNP identification; TGF 1; Type 2 diabetes

Indexed keywords

GELATINASE B; GENOMIC DNA; HYALURONAN SYNTHASE 2; HYALURONAN SYNTHASE 3; SYNTHETASE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; GLUCURONOSYLTRANSFERASE; HAS2 PROTEIN, HUMAN; HAS3 PROTEIN, HUMAN; MICROSATELLITE DNA;

ADULT; AGED; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA DETERMINATION; FEMALE; GENE IDENTIFICATION; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM; URINALYSIS; DNA MICROARRAY; DNA SEQUENCE; EXON; GENE FREQUENCY; GENETICS; MIDDLE AGED;

AGED; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; EXONS; FEMALE; GENE FREQUENCY; GENOTYPE; GLUCURONOSYLTRANSFERASE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MICROSATELLITE REPEATS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 52049099671     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med. 1989;320:1161-1165.
2. The Diabetes Control and Complications Trial Research Group. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes. 1997;46:1829-1839.
3. Ziyadeh FN. Mediators of diabetic renal disease: the case for TGF-β as the major mediator. J Am Soc Nephrol. 2004;15:S55-S57.
4. Keski-Oja J, Koli K, von Melchner H. TGF-β activation by traction? Trends Cell Biol. 2004;14:657-659.
5. Yu Q, Stamenkovic I. Cell surface-localized matrix metallo-proteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 2000;14:163-176.
6. Zhang XL, Selbi W, de la Motte C, Hascall VC, Phillips AO. Renal proximal tubular epithelial cell transforming growth factor-beta1 generation and monocyte binding. Am J Pathol. 2004;165:763-773.
7. Ito T, Williams JD, Fraser DJ, Phillips AO. Hyaluronan attenuates transforming growth factor-beta1-mediated signaling in renal proximal tubular epithelial cells. Am J Pathol. 2004;164:1979-1988.
8. Jones SG, Jones S, Phillips AO. Regulation of renal proximal tubular epithelial cell hyaluronan generation: implications for diabetic nephropathy. Kidney Int. 2001;59:1739-1749.
9. Norton N, Williams NM, O'Donovan MC, Owen MJ. DNA pooling as a tool for large-scale association studies in complex traits. Ann Med. 2004;36:146-152.
10. Maeda S, Haneda M, Guo B, et al. Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathy. Kidney Int. 2001;60:1428-1434.
11. Hirakawa S, Lange EM, Colicigno CJ, Freedman BI, Rich SS, Bowden DW. Evaluation of genetic variation and association in the matrix metalloproteinase 9 (MMP9) gene in ESRD patients. Am J Kidney Dis. 2003;42:133-142.
12. Kikuchi M, Matsumoto T, Ohashi Y. Risk factors for development of proteinuria in NIDDM analyzed by Poisson regression. J Diabet Complications. 1991;5:128-130.
13. Savage S, Nagel NJ, Estacio RO, Lukken N, Schrier RW. Clinical factors associated with urinary albumin excretion in type II diabetes. Am J Kidney Dis. 1995;25:836-844.
14. Blush J, Lei J, Ju W, Silbiger S, Pullman J, Neugarten J. Estradiol reverses renal injury in Alb/TGF-β1 transgenic mice. Kidney Int. 2004;66:2148-2154.
15. O'Donovan MC, Oefner PJ, Roberts SC, et al. Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection. Genomics. 1998;52:44-49.
16. Bowen T, Norton N, Jacobsen NJ, et al. Linked polymorphisms upstream of exons 1 and 2 of the human cholecystokinin gene are not associated with schizophrenia or bipolar disorder. Mol Psychiatry. 1998;3:67-71.
17. Bowen T, Guy CA, Speight G, et al. Expansion of 50 CAG/CTG repeats excluded in schizophrenia by application of a highly efficient approach using repeat expansion detection and a PCR screening set. Am J Hum Genet. 1996;59:912-917.
18. Sham PC, Curtis D. Monte-Carlo tests for association between disease and alleles at highly polymorphic loci. Ann Hum Genet. 1995;59:97-105.
19. Zhang B, Henney A, Eriksson P, Hamsten A, Watkins H, Ye S. Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1. Hum Genet. 1999;105:418-423.
20. Kumari K, Baggenstoss PA, Parker AL, Weigel PH. Mutation of two intramembrane polar residues conserved within the hyaluronan synthase family alters hyaluronan product size. J Biol Chem. 2006;281:11755-11760.
21. Patel A, Scott WR, Lympany PA, Rippin JD, Gill GV; Warren 3/UK GoKind Study Group. The TGF-β1 gene codon 10 polymorphism contributes to the genetic predisposition to nephropathy in type 1 diabetes. Diabet Med. 2005;22:69-73.
22. Wong TY, Poon P, Chow KM, Szeto CC, Cheung MK, Li PK. Association of transforming growth factor-beta (TGF-β) T869C (Leu 10 Pro) gene polymorphisms with type 2 diabetic nephropathy in Chinese patients. Kidney Int. 2003;63:1831-1835.
23. Wilkening S, Hemminki K, Rudnai P, et al. Case-control study in basal cell carcinoma of the skin: single nucleotide polymorphisms in three interleukin promoters pre-analysed in pooled DNA. Br J Dermatol. 2006;155:1139-1144.
24. Steer S, Abkevich V, Gutin A, et al. Genomic DNA pooling for whole-genome association scans in complex disease: empirical demonstration of efficacy in rheumatoid arthritis. Genes Immun. 2007;8:57-68.
25. Pearson JV, Huentelman MJ, Halperin RF, et al. Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies. Am J Hum Genet. 2007;80:126-139.